Baxalta Now Part Of Shire

This early-stage trial is testing a single injection of gene therapy for adults with hemophilia B. The goal is to see if the treatment is safe and if it can help the body produce its own missing clotting factor, potentially reducing or eliminating the need for regular injections.…

This study is monitoring the long-term safety of a medication called ADYNOVI/ADYNOVATE in people with Hemophilia A. It involves about 207 participants who are already using this drug as part of their regular care to prevent bleeding episodes. The main goal is to check for any sid…